Harold J. Burstein

1991–2025 年に発表

159
論文数
49,682
被引用数
102
h 指数
157
i10 指数

被引用数

Harold J. Burstein の年別被引用数1974 年: 被引用 1 件1981 年: 被引用 2 件1992 年: 被引用 4 件1993 年: 被引用 16 件1994 年: 被引用 12 件1995 年: 被引用 10 件1996 年: 被引用 18 件1997 年: 被引用 12 件1998 年: 被引用 11 件1999 年: 被引用 12 件2000 年: 被引用 25 件2001 年: 被引用 22 件2002 年: 被引用 47 件2003 年: 被引用 91 件2004 年: 被引用 93 件2005 年: 被引用 126 件2006 年: 被引用 166 件2007 年: 被引用 165 件2008 年: 被引用 202 件2009 年: 被引用 283 件2010 年: 被引用 310 件2011 年: 被引用 296 件2012 年: 被引用 299 件2013 年: 被引用 277 件2014 年: 被引用 295 件2015 年: 被引用 389 件2016 年: 被引用 378 件2017 年: 被引用 370 件2018 年: 被引用 330 件2019 年: 被引用 1,317 件2020 年: 被引用 1,512 件2021 年: 被引用 1,385 件2022 年: 被引用 1,091 件2023 年: 被引用 880 件2024 年: 被引用 1,562 件2025 年: 被引用 728 件2026 年: 被引用 32 件1975〜1980 年は被引用が無いため表示していません1982〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,208 件、この内訳の 23.9%中国: 引用元論文 1,840 件、この内訳の 10.5%イタリア: 引用元論文 1,139 件、この内訳の 6.5%イギリス: 引用元論文 927 件、この内訳の 5.3%ドイツ: 引用元論文 816 件、この内訳の 4.6%フランス: 引用元論文 649 件、この内訳の 3.7%カナダ: 引用元論文 623 件、この内訳の 3.6%スペイン: 引用元論文 552 件、この内訳の 3.1%スイス: 引用元論文 503 件、この内訳の 2.9%ベルギー: 引用元論文 461 件、この内訳の 2.6%オランダ: 引用元論文 438 件、この内訳の 2.5%オーストラリア: 引用元論文 428 件、この内訳の 2.4%
0%23.9%その他 28.4%

分野

  • Medicine55.4%
  • Biochemistry, Genetics and Molecular Biology35.5%
  • Computer Science2.2%
  • Immunology and Microbiology1.9%
  • Engineering1.2%
  • Materials Science0.7%
  • その他3.1%

トピック

  • Breast Cancer Treatment Studies11.3%
  • HER2/EGFR in Cancer Research6.4%
  • Advanced Breast Cancer Therapies4.4%
  • Breast Lesions and Carcinomas3.9%
  • Cancer Treatment and Pharmacology3.2%
  • Estrogen and related hormone effects2.4%
  • その他68.4%

共著者

全論文

検索で開く
  1. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph A. Sparano, Tanja Španić, Sandra M. Swain, Sergei Tjulandin, Masakazu Toi, Dario Trapani, Andrew Tutt, B. Xu, Giuseppe Curigliano, Nadia Harbeck - Annals of Oncology 2023 被引用: 844

  2. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood - Annals of Oncology 2013 被引用: 3,715

  3. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Erica Stringer-Reasor, Melinda L. Telli, John H. Ward, Kari B. Wisinski, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2022 被引用: 964

  4. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy E. Garber, Michael Gnant, William J. Gradishar, Bahadır M. Güllüoğlu, Nadia Harbeck, Chiun‐Sheng Huang, Jens Huober, André Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith M. Regan, Isabella Rubio, Hope S. Rugo, Emiel J. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Španić, Petra Tesařová, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, William P. Weber, Eric P. Winer, Binghe Xu - Annals of Oncology 2021 被引用: 803

  5. NCCN Guidelines® Insights: Breast Cancer, Version 4.2023

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melinda L. Telli, Mei Wei, Kari B. Wisinski, Jessica Young, Kay T. Yeung, Mary A. Dwyer, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2023 被引用: 440

  6. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melinda L. Telli, John H. Ward, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2020 被引用: 1,618

  7. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, Mei Wei, Kari B. Wisinski, Kay T. Yeung, Jessica Young, Ryan Schonfeld, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2024 被引用: 560

  8. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gϋnter von Minckwitz, Toru Watanabe, Timothy J. Whelan, Eric P. Winer, Binghe Xu - Annals of Oncology 2015 被引用: 1,837

  9. Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update

    著者: , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 299

  10. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giuseppe Curigliano, Jana de Boniface, Suzette Delaloge, A. DeMichele, Carsten Denkert, Gerd Fastner, Florian Fitzal, Prudence A. Francis, H Gamal, Oreste ­Gentilini, Michael Gnant, William J. Gradishar, B. Gulluoglu, Nadia Harbeck, Jörg Heil, Chien Shiun Huang, Jens Huober, Zeping Jiang, Orit Kaidar‐Person, Marleen Kok, Eun‐So Lee, Sherene Loi, S. Loibl, Miguel Martín, Icro Meattini, Monica Morrow, A. H. Partridge, Frédérique Penault‐Llorca, Martine Piccart, Lori J. Pierce, Philip Poortmans, Meredith M. Regan, J. S. Reis-Filho, Isabel T. Rubio, Hope S. Rugo, Emiel J. Rutgers, Cristina Saura, Elżbieta Senkus, Zhi-Ming Shao, Christian F. Singer, Tanja Španič, Beat Thuerlimann, Masakazu Toi, Sara M. Tolaney, Nicholas C. Turner, Andrew Tutt, M.-J. Vrancken Peeters, Toru Watanabe, William P. Weber, Hans Wildiers, B. Xu - Annals of Oncology 2023 被引用: 221

  11. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiun‐Sheng Huang, Jens Huober, Hussein Khaled, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, Kent C. Osborne, Olivia Pagani, Ann H. Partridge, K. Pritchard, Jungsil Ro, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Toru Watanabe, Timothy J. Whelan, Binghe Xu - Annals of Oncology 2017 被引用: 1,255

  12. Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer

    著者: - New England Journal of Medicine 2020 被引用: 317

  13. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

    著者: , , , , , , , , , , , , - Annals of Oncology 2019 被引用: 690

  14. Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 630

  15. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 165

  16. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Ruepp, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan - New England Journal of Medicine 2018 被引用: 673

  17. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 154

  18. Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 645

  19. Testing for ESR1 Mutations to Guide Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update

    著者: , , , , - Journal of Clinical Oncology 2023 被引用: 98

  20. Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Miguel Gil‐Gil, Aleix Prat, Hannes Fohler, Otto Metzger, Magdalena Schwarz, Carter DuFrane, Debora Fumagalli, Kathy Puyana Theall, Dongrui R. Lu, Cynthia Huang Bartlett, María Koehler, Christian Fesl, Angela DeMichele, Michael Gnant - The Lancet Oncology 2021 被引用: 255

  21. PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2024 被引用: 109

  22. Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard D. Gelber, Aron Goldhirsch, Prudence A. Francis - New England Journal of Medicine 2014 被引用: 747

  23. Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 748

  24. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 被引用: 1,893